Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor Develops Wearable Medical Alert System for Individuals with Heart Disease (TRO-300)


PITTSBURGH, Aug. 5, 2020 /PRNewswire/ -- It's been proven over and over again that time is of the essence when someone experiences the signs of a heart attack. With that in mind, an inventor from Mississauga, Ontario, has come up with a device that can provide a quick, life-saving response to signs of a heart attack.

He developed CODE BLUE ALERT PENDANT, patent-pending, to afford immediate access to aspirin and medical assistance in such cases. By sending the location of the patient to emergency medical services, it has the potential to prevent serious heart damage and deaths. Lightweight, compact and portable, this novel device not only saves time and effort, it is also easy to use. In addition, users will appreciate how convenient, effective and affordably priced it is.

The inventor's personal observation inspired the idea. "I realized it takes too long to find and take aspirin and then call for help in the event of a heart attack," he said. "This device will reduce response time significantly."

The original design was submitted to the Toronto sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-TRO-300, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 10:00
Bernhard, one of America's largest privately-owned infrastructure firms, announced a groundbreaking 30-year Energy-as-a-Service (EaaS) partnership with Hackensack Meridian Health (HMH), New Jersey's largest health network....

at 10:00
Ziegler, a specialty investment bank, is pleased to announce its role as exclusive sell-side advisor to Retirement Housing Foundation (hereafter "RHF") on the sale of its 15-community senior living portfolio located across six states: California (7...

at 09:55
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has been named an Edison Award Winner in the 2024 Edison Awards, for the second year in a row. Viz PE with right ventricle/left ventricle...

at 09:50
The "Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Region - Analysis and Forecast, 2024-2033" report has been added to...

at 09:43
Discover new ways to make your skin BLOOM! Beekman 1802's top selling skin barrier-building formula, Bloom Cream Daily Face Moisturizer, is now available in two NEW formats that will make blooming even better! Introducing the Bloom Cream in a Tube...

at 09:00
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5374, a phase 1/2a study evaluating the safety, tolerability, and antiviral effect of a novel combination regimen that includes...



News published on and distributed by: